Valuation GENFIT Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 20:54:01 30/06/2026 BST			5-day change	1st Jan Change
10.61 ^EUR	+5.47%		-1.32%	+100.19%

06-24	Oddo BHF Still Positive on Genfit
06-24	Genfit's Investigative Treatment for Bile Duct Cancer Shows Positive Results in Phase 1b Study	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	154.9	214.6	197	176	176.3	527.8	527.8	-
Change	-	38.52%	-8.19%	-10.69%	0.17%	199.44%	0%	-
Enterprise Value (EV) ¹	169.6	30.1	131.8	168.4	156.6	166.7	481	471
Change	-	-82.25%	337.75%	27.79%	-6.98%	6.41%	1.66%	-2.08%
P/E	-1.54x	3.51x	-8.27x	-6.1x	118x	-3.06x	55.7x	70.4x
PBR	-9.5x	2.55x	-	2.59x	2.54x	5.76x	6.74x	8.09x
PEG	-	-0x	0x	-0.3x	-1x	0x	-0x	-3.4x
Capitalization / Revenue	20x	2.51x	7.42x	4.61x	2.48x	3.69x	5.54x	4.43x
EV / Revenue	21.9x	0.35x	4.96x	4.41x	2.21x	2.34x	5.05x	3.95x
EV / EBITDA	-2.29x	0.87x	-5.18x	-6.75x	31.3x	-3.22x	17.1x	7.76x
EV / EBIT	-2.19x	0.95x	-4.83x	-6.33x	47.7x	-37x	16.5x	7.72x
EV / FCF	-1.74x	0.3x	-	-3.02x	10.7x	-6.04x	-40.1x	9,419x
FCF Yield	-57.4%	330%	-	-33.2%	9.35%	-16.6%	-2.49%	0.01%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.6	1.23	-0.48	-0.58	0.03	-1.72	0.1901	0.1506
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7.758	85.58	26.57	38.18	70.94	71.12	95.2	119.3
EBITDA ¹	-74.03	34.56	-25.46	-24.93	5.005	-51.79	28.08	60.67
EBIT ¹	-77.59	31.82	-27.29	-26.58	3.281	-4.5	29.22	61
Net income ¹	-101.2	67.26	-23.72	-28.89	1.507	-85.97	18.31	0.0333
Net Debt ¹	14.66	-184.5	-65.28	-7.611	-19.66	-95.52	-46.87	-56.87
Reference price ²	3.99	4.32	3.97	3.54	3.54	10.60	10.60	10.60
Nbr of stocks (in thousands)	38,811	49,727	49,655	49,712	49,865	49,795	49,795	-
Announcement Date	01/04/21	07/04/22	13/04/23	04/04/24	24/04/25	02/04/26	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	32.51x	5.73x	17.74x	1.01%	46.62B
REVOLUTION MEDICINES, INC.	-24.23x	362.81x	-23.24x	-.--%	40.95B
IQVIA HOLDINGS INC.	23.52x	2.66x	11.48x	-.--%	32.26B
BEONE MEDICINES AG	43.26x	4.35x	27.86x	-.--%	32.24B
CELLTRION, INC.	30.17x	7.79x	20.04x	0.42%	25.53B
MEDPACE HOLDINGS, INC.	31.37x	5.08x	23.16x	-.--%	15.27B
EUROFINS SCIENTIFIC SE	23.68x	2.02x	8.88x	1.13%	13.61B
IONIS PHARMACEUTICALS, INC.	-22.39x	14.68x	-21.96x	-.--%	13.34B
Average	17.24x	50.64x	7.99x	0.32%	27.48B
Weighted average by Cap.	17.97x	72.11x	8.36x	0.33%